• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

急性和慢性乙型肝炎中核心特异性辅助性T细胞和细胞毒性T淋巴细胞活性的定量与功能分析

Quantitative and functional analysis of core-specific T-helper cell and CTL activities in acute and chronic hepatitis B.

作者信息

Löhr H F, Krug S, Herr W, Weyer S, Schlaak J, Wölfel T, Gerken G, Meyer zum Büschenfelde K H

机构信息

Department of Internal Medicine, Johannes-Gutenberg-University, Mainz, Germany.

出版信息

Liver. 1998 Dec;18(6):405-13. doi: 10.1111/j.1600-0676.1998.tb00825.x.

DOI:10.1111/j.1600-0676.1998.tb00825.x
PMID:9869395
Abstract

AIMS/BACKGROUND: CD4+ T-helper cell (Th) responses to hepatitis B virus (HBV) core antigen (HBc) are increased during exacerbations in acute and chronic hepatitis B (AHB, CHB) and might influence the induction of CD8+ cytotoxic T lymphocytes (CTL) that are important for viral clearance.

METHODS

HBc-specific proliferative responses and cytokine release of blood mononuclear cells (PBMC) were studied in patients with AHB or CHB, as well as responders and non-responders to interferon-alpha treatment (IFN-R, IFN-NR), by [3H]-thymidine-uptake, enzyme-linked immunosorbent assay (ELISA) and Elispot assay and were compared to peptide HBc18 27-specific CTL precursor frequencies among CD8+ T cells derived from HLA-A2+ patients.

RESULTS

HBc-specific proliferative PBMC responses and Th frequencies were significantly increased in AHB patients compared with untreated CHB patients. PBMC derived from IFN-R showed stronger cellular responses than IFN-NR. Stimulated PBMC from all patient groups secreted significantly more IFN-gamma than IL-4 indicating Th1/Th0 cell responses. Furthermore, in AHB and IFN-R patients, high peptide HBc18-27-specific CTL precursor frequencies closely correlated with strong HBc-specific Th responses, whereas in untreated CHB and IFN-NR patients lower CTL frequencies were observed without correlation to Th activities.

CONCLUSIONS

HBV core-specific Th-cell responses appeared to support efficient CTL induction in patients with viral clearance, whereas in chronic HBV carriers quantitatively insufficient Th and CTL responses were observed. This observation could be important for future therapeutic strategies.

摘要

目的/背景:在急性和慢性乙型肝炎(AHB、CHB)病情加重期间,CD4 +辅助性T细胞(Th)对乙型肝炎病毒(HBV)核心抗原(HBc)的反应增强,这可能会影响对病毒清除至关重要的CD8 +细胞毒性T淋巴细胞(CTL)的诱导。

方法

通过[3H] - 胸腺嘧啶核苷摄取、酶联免疫吸附测定(ELISA)和酶联免疫斑点测定(Elispot assay),研究了AHB或CHB患者以及α干扰素治疗的应答者和无应答者(IFN-R、IFN-NR)中HBc特异性增殖反应和血液单核细胞(PBMC)的细胞因子释放,并与来自HLA-A2 +患者的CD8 + T细胞中肽HBc18 - 27特异性CTL前体频率进行比较。

结果

与未经治疗的CHB患者相比,AHB患者中HBc特异性增殖PBMC反应和Th频率显著增加。来自IFN-R的PBMC显示出比IFN-NR更强的细胞反应。所有患者组刺激后的PBMC分泌的IFN-γ明显多于IL-4,表明存在Th1/Th0细胞反应。此外,在AHB和IFN-R患者中,高肽HBc18 - 27特异性CTL前体频率与强烈的HBc特异性Th反应密切相关,而在未经治疗的CHB和IFN-NR患者中,观察到较低的CTL频率,且与Th活性无关。

结论

HBV核心特异性Th细胞反应似乎支持病毒清除患者中有效的CTL诱导,而在慢性HBV携带者中观察到Th和CTL反应在数量上不足。这一观察结果可能对未来的治疗策略很重要。

相似文献

1
Quantitative and functional analysis of core-specific T-helper cell and CTL activities in acute and chronic hepatitis B.急性和慢性乙型肝炎中核心特异性辅助性T细胞和细胞毒性T淋巴细胞活性的定量与功能分析
Liver. 1998 Dec;18(6):405-13. doi: 10.1111/j.1600-0676.1998.tb00825.x.
2
Induction of strong hepatitis B virus (HBV) specific T helper cell and cytotoxic T lymphocyte responses by therapeutic vaccination in the trimera mouse model of chronic HBV infection.在慢性乙型肝炎病毒(HBV)感染的三聚体小鼠模型中,通过治疗性疫苗接种诱导强烈的HBV特异性辅助性T细胞和细胞毒性T淋巴细胞反应。
Eur J Immunol. 2001 Jul;31(7):2071-9. doi: 10.1002/1521-4141(200107)31:7<2071::aid-immu2071>3.0.co;2-d.
3
[Detection of antigen-epitope-specific cytotoxic T lymphocytes in patients with hepatitis B virus infection by enzyme linked immunospot assay].[酶联免疫斑点法检测乙型肝炎病毒感染患者抗原表位特异性细胞毒性T淋巴细胞]
Zhonghua Yu Fang Yi Xue Za Zhi. 2009 Aug;43(8):690-4.
4
[Dendritic cells originated from the peripheral blood in chronic hepatitis B patients can induce specific T cell immune response].慢性乙型肝炎患者外周血来源的树突状细胞可诱导特异性T细胞免疫应答
Zhonghua Gan Zang Bing Za Zhi. 2003 Oct;11(10):588-91.
5
[Dynamic changes and clinical significance of HBcAg18-27 specific cytotoxic T lymphocytes in acute hepatitis B patients].[急性乙型肝炎患者中HBcAg18-27特异性细胞毒性T淋巴细胞的动态变化及临床意义]
Zhonghua Gan Zang Bing Za Zhi. 2011 Jan;19(1):38-43. doi: 10.3760/cma.j.issn.1007-3418.2011.01.011.
6
Hepatitis B core antigen is a potent inductor of interleukin-18 in peripheral blood mononuclear cells of healthy controls and patients with hepatitis B infection.乙肝核心抗原是健康对照者和乙肝感染患者外周血单个核细胞中白细胞介素-18的强效诱导剂。
J Med Virol. 2003 Sep;71(1):31-40. doi: 10.1002/jmv.10445.
7
Induction of T-helper cell response to hepatitis B core antigen in chronic hepatitis B: a major factor in activation of the host immune response to the hepatitis B virus.慢性乙型肝炎中T辅助细胞对乙肝核心抗原反应的诱导:宿主对乙肝病毒免疫反应激活的一个主要因素。
Hepatology. 1995 Oct;22(4 Pt 1):1040-9. doi: 10.1016/0270-9139(95)90607-x.
8
[The effect of stimulation of dendritic cell on HBV-epitopic cytotoxic T-lymphocyte].[树突状细胞刺激对乙肝病毒表位细胞毒性T淋巴细胞的影响]
Zhonghua Yi Xue Za Zhi. 2005 May 11;85(17):1171-6.
9
Hepatitis B virus-specific T-cell proliferation and cytokine secretion in chronic hepatitis B e antibody-positive patients treated with ribavirin and interferon alpha.接受利巴韦林和α干扰素治疗的慢性乙型肝炎e抗体阳性患者中乙肝病毒特异性T细胞增殖及细胞因子分泌情况
Hepatology. 2001 Jan;33(1):295-300. doi: 10.1053/jhep.2001.21147.
10
Immunogenicity of twenty peptides representing epitopes of the hepatitis B core and surface antigens by IFN-γ response in chronic and resolved HBV.通过慢性和已治愈乙肝患者的γ干扰素反应评估代表乙肝核心抗原和表面抗原表位的20种肽的免疫原性
BMC Immunol. 2015 Nov 2;16:65. doi: 10.1186/s12865-015-0127-7.

引用本文的文献

1
Role of Common Fractalkine Receptor Variants with Chronic Hepatitis B Patients in Tunisia.常见趋化因子受体变体在突尼斯慢性乙型肝炎患者中的作用
Viruses. 2025 Jul 10;17(7):968. doi: 10.3390/v17070968.
2
Application Effect and Accuracy Analysis of Electrochemiluminescence Immunoassay and Enzyme-Linked Immunosorbent Assay in the Serological Test of Hepatitis B Virus.电化学发光免疫分析法与酶联免疫吸附测定法在乙型肝炎病毒血清学检测中的应用效果及准确性分析
Evid Based Complement Alternat Med. 2022 Aug 4;2022:9371497. doi: 10.1155/2022/9371497. eCollection 2022.
3
A dendritic cell receptor-targeted chimeric immunotherapeutic protein (C-HBV) for the treatment of chronic hepatitis B.
一种用于治疗慢性乙型肝炎的树突状细胞受体靶向嵌合免疫治疗蛋白(C-HBV)。
Hum Vaccin Immunother. 2020 Apr 2;16(4):756-778. doi: 10.1080/21645515.2019.1689080. Epub 2019 Dec 12.
4
Immunopathogenesis of hepatitis B persistent infection: implications for immunotherapeutic strategies.乙型肝炎持续感染的免疫发病机制:对免疫治疗策略的启示
Clin J Gastroenterol. 2009 Apr;2(2):71-79. doi: 10.1007/s12328-009-0074-z. Epub 2009 Mar 27.
5
Osteopontin promotes dendritic cell maturation and function in response to HBV antigens.骨桥蛋白可促进树突状细胞对乙肝病毒抗原产生应答时的成熟及功能。
Drug Des Devel Ther. 2015 Jun 12;9:3003-16. doi: 10.2147/DDDT.S81656. eCollection 2015.
6
Immunosuppressive drugs modulate the replication of hepatitis B virus (HBV) in a hydrodynamic injection mouse model.免疫抑制药物在水动力注射小鼠模型中调节乙型肝炎病毒(HBV)的复制。
PLoS One. 2014 Jan 21;9(1):e85832. doi: 10.1371/journal.pone.0085832. eCollection 2014.
7
Sustained and transient oscillations and chaos induced by delayed antiviral immune response in an immunosuppressive infection model.免疫抑制感染模型中延迟抗病毒免疫反应诱导的持续振荡、瞬态振荡和混沌
J Math Biol. 2014 Jan;68(1-2):477-503. doi: 10.1007/s00285-012-0639-1. Epub 2013 Jan 11.
8
CTLA-4 exon 1 +49 polymorphism alone and in a haplotype with -318 promoter polymorphism may confer susceptibility to chronic HBV infection in Chinese Han patients.CTLA-4 外显子 1 +49 多态性单独存在或与 -318 启动子多态性形成单倍型可能与中国汉族慢性 HBV 感染者的易感性相关。
Mol Biol Rep. 2011 Nov;38(8):5125-32. doi: 10.1007/s11033-010-0660-7. Epub 2010 Dec 15.
9
Expression of hepatitis B virus x protein in hepatocytes suppresses CD8 T cell activity.乙型肝炎病毒 X 蛋白在肝细胞中的表达抑制了 CD8 T 细胞的活性。
Immune Netw. 2010 Aug;10(4):126-34. doi: 10.4110/in.2010.10.4.126. Epub 2010 Aug 31.
10
Implication of Th17 and Th1 cells in patients with chronic active hepatitis B.辅助性 T 细胞 17 和 1 细胞在慢性乙型肝炎活动期患者中的意义。
J Clin Immunol. 2010 Jan;30(1):60-7. doi: 10.1007/s10875-009-9328-2. Epub 2009 Sep 10.